194 related articles for article (PubMed ID: 8641982)
21. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
Haas K; Staller P; Geisen C; Bartek J; Eilers M; Möröy T
Oncogene; 1997 Jul; 15(2):179-92. PubMed ID: 9244353
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec H; Grzeschiczek A; Kowalski MB; Möröy T
EMBO J; 1994 Aug; 13(15):3487-95. PubMed ID: 8062825
[TBL] [Abstract][Full Text] [Related]
23. Specific transformation abolishes cyclin D1 fluctuation throughout the cell cycle.
Pusch O; Soucek T; Wawra E; Hengstschläger-Ottnad E; Bernaschek G; Hengstschläger M
FEBS Lett; 1996 May; 385(3):143-8. PubMed ID: 8647239
[TBL] [Abstract][Full Text] [Related]
24. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.
Nakagawa H; Wang TC; Zukerberg L; Odze R; Togawa K; May GH; Wilson J; Rustgi AK
Oncogene; 1997 Mar; 14(10):1185-90. PubMed ID: 9121767
[TBL] [Abstract][Full Text] [Related]
25. Induction of cyclin D1 overexpression by activated ras.
Filmus J; Robles AI; Shi W; Wong MJ; Colombo LL; Conti CJ
Oncogene; 1994 Dec; 9(12):3627-33. PubMed ID: 7970723
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic potential of BRAF versus RAS.
Benjamin CL; Ananthaswamy HN
Cancer Lett; 2008 Mar; 261(2):137-46. PubMed ID: 18280030
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.
Chen Q; Lin J; Jinno S; Okayama H
Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the cell cycle machinery by oncogenic ras.
Winston JT; Coats SR; Wang YZ; Pledger WJ
Oncogene; 1996 Jan; 12(1):127-34. PubMed ID: 8552383
[TBL] [Abstract][Full Text] [Related]
30. Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities.
Ruggeri BA; Bauer B; Zhang SY; Klein-Szanto AJ
Carcinogenesis; 1994 Aug; 15(8):1613-9. PubMed ID: 8055640
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
Musgrove EA; Lee CS; Buckley MF; Sutherland RL
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8022-6. PubMed ID: 8058751
[TBL] [Abstract][Full Text] [Related]
32. Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene.
Rao RN; Stamm NB; Otto K; Kovacevic S; Watkins SA; Rutherford P; Lemke S; Cocke K; Beckmann RP; Houck K; Johnson D; Skidmore BJ
Oncogene; 1999 Nov; 18(46):6343-56. PubMed ID: 10597234
[TBL] [Abstract][Full Text] [Related]
33. Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells.
Asano K; Sakamoto H; Sasaki H; Ochiya T; Yoshida T; Ohishi Y; Machida T; Kakizoe T; Sugimura T; Terada M
Biochem Biophys Res Commun; 1995 Dec; 217(3):1169-76. PubMed ID: 8554573
[TBL] [Abstract][Full Text] [Related]
34. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines.
Kurzrock R; Ku S; Talpaz M
Cancer; 1995 Jan; 75(2):584-90. PubMed ID: 7812927
[TBL] [Abstract][Full Text] [Related]
35. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.
Rosenberg CL; Motokura T; Kronenberg HM; Arnold A
Oncogene; 1993 Feb; 8(2):519-21. PubMed ID: 8426754
[TBL] [Abstract][Full Text] [Related]
36. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
[TBL] [Abstract][Full Text] [Related]
37. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes.
Arber N; Sutter T; Miyake M; Kahn SM; Venkatraj VS; Sobrino A; Warburton D; Holt PR; Weinstein IB
Oncogene; 1996 May; 12(9):1903-8. PubMed ID: 8649851
[TBL] [Abstract][Full Text] [Related]
40. PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint.
Motokura T; Arnold A
Genes Chromosomes Cancer; 1993 Jun; 7(2):89-95. PubMed ID: 7687458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
